The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo
Kirsten J. Koymans(University Medical Center Utrecht), Eva Medina(Helmholtz Centre for Infection Research), Oliver Goldmann(Helmholtz Centre for Infection Research), Wiedjai Sital(University Medical Center Utrecht), Christofer Karlsson(Lund University), Johan Malmström(Lund University), Manouk Vrieling(University Medical Center Utrecht), Kok P. M. van Kessel(University Medical Center Utrecht), Jos A. G. van Strijp(University Medical Center Utrecht), Robert Thänert(Washington University in St. Louis), Carla J. C. de Haas(University Medical Center Utrecht), Adinda Bisschop(University Medical Center Utrecht)
Cited by 30
Related Papers
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus
|Frontiers in Immunology|2014|188
Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections
|mBio|2019|116
Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions
|The Journal of Infectious Diseases|2020|81
Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection
|Nature Communications|2017|73
The resistance within: Antibiotic disruption of the gut microbiome and resistome dynamics in infancy
|Cell Host & Microbe|2022|71